{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:56:55Z","timestamp":1789624615633,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Hunan Provincial Natural Regional Joint Fund","award":["2025JJ70502"],"award-info":[{"award-number":["2025JJ70502"]}]},{"name":"the Science and Technology Guidance Project of Yongzhou, China","award":["2022-YZKJZD-023"],"award-info":[{"award-number":["2022-YZKJZD-023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-36704-x","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T08:07:40Z","timestamp":1770106060000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["NMR metabolomic signatures of healthy lifestyle and incident MASLD"],"prefix":"10.1038","volume":"16","author":[{"given":"Xin","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihua","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"36704_CR1","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","volume":"35","author":"L Miao","year":"2024","unstructured":"Miao, L., Targher, G., Byrne, C. D., Cao, Y. Y. & Zheng, M. H. Current status and future trends of the global burden of MASLD. Trends Endocrinol. Metab. 35, 697\u2013707 (2024).","journal-title":"Trends Endocrinol. Metab."},{"key":"36704_CR2","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1111\/apt.70020","volume":"61","author":"ZM Younossi","year":"2025","unstructured":"Younossi, Z. M. et al. Addressing the high and rising global burden of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (Mash): From the growing prevalence to payors\u2019 perspective. Aliment Pharmacol. Ther. 61, 1467\u20131478 (2025).","journal-title":"Aliment Pharmacol. Ther."},{"key":"36704_CR3","doi-asserted-by":"publisher","first-page":"101898","DOI":"10.1016\/j.aohep.2025.101898","volume":"30","author":"C Kan","year":"2025","unstructured":"Kan, C. et al. Global burden and future trends of metabolic dysfunction-associated steatotic liver disease: 1990\u20132021 to 2045. Ann. Hepatol. 30, 101898 (2025).","journal-title":"Ann. Hepatol."},{"key":"36704_CR4","doi-asserted-by":"publisher","first-page":"101271","DOI":"10.1016\/j.jhepr.2024.101271","volume":"7","author":"G Feng","year":"2025","unstructured":"Feng, G. et al. Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021. JHEP Rep. 7, 101271 (2025).","journal-title":"JHEP Rep."},{"key":"36704_CR5","doi-asserted-by":"publisher","first-page":"103043","DOI":"10.1016\/j.arcmed.2024.103043","volume":"55","author":"E Amini-Salehi","year":"2024","unstructured":"Amini-Salehi, E. et al. Global prevalence of nonalcoholic fatty liver disease: An updated review meta-analysis comprising a population of 78 million from 38 countries. Arch. Med. Res. 55, 103043 (2024).","journal-title":"Arch. Med. Res."},{"key":"36704_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.puhe.2025.02.028","volume":"242","author":"Y Gu","year":"2025","unstructured":"Gu, Y. et al. The trend in incidence of non-alcoholic fatty liver disease and its impact on cirrhosis and liver cancer: An analysis from global burden of disease 2021. Public Health 242, 79\u201386 (2025).","journal-title":"Public Health"},{"key":"36704_CR7","doi-asserted-by":"publisher","first-page":"e0583","DOI":"10.1097\/HC9.0000000000000583","volume":"8","author":"LS Grinshpan","year":"2024","unstructured":"Grinshpan, L. S. et al. A healthy lifestyle is prospectively associated with lower onset of metabolic dysfunction-associated steatotic liver disease. Hepatol Commun. 8, e0583 (2024).","journal-title":"Hepatol Commun."},{"key":"36704_CR8","doi-asserted-by":"publisher","first-page":"107971","DOI":"10.1016\/j.ypmed.2024.107971","volume":"184","author":"S Zhang","year":"2024","unstructured":"Zhang, S. et al. Adherence to a healthy lifestyle including sleep and sedentary behaviors and risk of metabolic dysfunction-associated steatotic liver disease in Chinese adults. Prev. Med. 184, 107971 (2024).","journal-title":"Prev. Med."},{"key":"36704_CR9","doi-asserted-by":"publisher","first-page":"1421386","DOI":"10.3389\/fnut.2024.1421386","volume":"11","author":"MJ Chen","year":"2024","unstructured":"Chen, M. J. et al. Evidence summary of lifestyle interventions in adults with metabolic dysfunction-associated steatotic liver disease. Front Nutr. 11, 1421386 (2024).","journal-title":"Front Nutr."},{"key":"36704_CR10","doi-asserted-by":"publisher","first-page":"155643","DOI":"10.1016\/j.metabol.2023.155643","volume":"146","author":"P He","year":"2023","unstructured":"He, P. et al. A healthy lifestyle, life\u2019s essential 8 scores and new-onset severe NAFLD: A prospective analysis in UK biobank. Metabolism 146, 155643 (2023).","journal-title":"Metabolism"},{"key":"36704_CR11","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s10654-022-00868-3","volume":"37","author":"S Yuan","year":"2022","unstructured":"Yuan, S. et al. Lifestyle and metabolic factors for nonalcoholic fatty liver disease: Mendelian randomization study. Eur. J. Epidemiol. 37, 723\u2013733 (2022).","journal-title":"Eur. J. Epidemiol."},{"key":"36704_CR12","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41575-023-00800-4","volume":"20","author":"ZM Younossi","year":"2023","unstructured":"Younossi, Z. M., Zelber-Sagi, S., Henry, L. & Gerber, L. H. Lifestyle interventions in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 20, 708\u2013722 (2023).","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"36704_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/eurjpc\/zwac252","volume":"30","author":"Z Fu","year":"2023","unstructured":"Fu, Z. et al. Association between nmr metabolomic signatures of healthy lifestyle and incident coronary artery disease. Eur. J. Prev. Cardiol. 30, 243\u2013253 (2023).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"36704_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.atherosclerosis.2022.12.008","volume":"367","author":"Q Lu","year":"2023","unstructured":"Lu, Q. et al. Healthy lifestyle, plasma metabolites, and risk of cardiovascular disease among individuals with diabetes. Atherosclerosis 367, 48\u201355 (2023).","journal-title":"Atherosclerosis"},{"key":"36704_CR15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ajcnut.2023.04.034","volume":"118","author":"J Zhang","year":"2023","unstructured":"Zhang, J. et al. Metabolic signature of healthy lifestyle and risk of rheumatoid arthritis: Observational and Mendelian randomization study. Am. J. Clin. Nutr. 118, 183\u2013193 (2023).","journal-title":"Am. J. Clin. Nutr."},{"key":"36704_CR16","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12933-023-01912-6","volume":"22","author":"S Rios","year":"2023","unstructured":"Rios, S. et al. Plasma metabolite profiles associated with the world cancer research fund\/American institute for cancer research lifestyle score and future risk of cardiovascular disease and type 2 diabetes. Cardiovasc. Diabetol. 22, 252 (2023).","journal-title":"Cardiovasc. Diabetol."},{"key":"36704_CR17","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1038\/s41598-025-86030-x","volume":"15","author":"T Jin","year":"2025","unstructured":"Jin, T. et al. The association between metabolomic profiles of lifestyle and the latent phase of incident chronic kidney disease in the UK population. Sci Rep. 15, 2299 (2025).","journal-title":"Sci Rep."},{"key":"36704_CR18","doi-asserted-by":"publisher","first-page":"10645","DOI":"10.1038\/s41598-024-61440-5","volume":"14","author":"R Zheng","year":"2024","unstructured":"Zheng, R. & Lind, L. A combined observational and Mendelian randomization investigation reveals Nmr-measured analytes to be risk factors of major cardiovascular diseases. Sci. Rep. 14, 10645 (2024).","journal-title":"Sci. Rep."},{"key":"36704_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.atherosclerosis.2023.01.012","volume":"367","author":"T Tesorio","year":"2023","unstructured":"Tesorio, T., Mone, P., de Donato, A., Trimarco, V. & Santulli, G. Linking lifestyle factors to cardiovascular risk through metabolomics: Insights from a large population of diabetic patients followed-up for 11 Years. Atherosclerosis 367, 37\u201339 (2023).","journal-title":"Atherosclerosis"},{"key":"36704_CR20","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.3390\/nu16081235","volume":"16","author":"C Fotakis","year":"2024","unstructured":"Fotakis, C. et al. Circulatory metabolite ratios as indicators of lifestyle risk factors based on a Greek Nafld case-control study. Nutrients. 16, 1235 (2024).","journal-title":"Nutrients."},{"key":"36704_CR21","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jhep.2021.10.013","volume":"76","author":"PK Luukkonen","year":"2022","unstructured":"Luukkonen, P. K. et al. Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease. J. Hepatol. 76, 526\u2013535 (2022).","journal-title":"J. Hepatol."},{"key":"36704_CR22","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1021\/pr200047c","volume":"10","author":"H Li","year":"2011","unstructured":"Li, H. et al. A Proton nuclear magnetic resonance metabonomics approach for biomarker discovery in nonalcoholic fatty liver disease. J. Proteome Res. 10, 2797\u20132806 (2011).","journal-title":"J. Proteome Res."},{"key":"36704_CR23","doi-asserted-by":"publisher","first-page":"n604","DOI":"10.1136\/bmj.n604","volume":"373","author":"YB Zhang","year":"2021","unstructured":"Zhang, Y. B. et al. Associations of healthy lifestyle and socioeconomic status with mortality and incident cardiovascular disease: Two prospective cohort studies. BMJ 373, n604 (2021).","journal-title":"BMJ"},{"key":"36704_CR24","doi-asserted-by":"publisher","first-page":"1230457","DOI":"10.3389\/fendo.2023.1230457","volume":"14","author":"C Fotakis","year":"2023","unstructured":"Fotakis, C. et al. Serum metabolomic profiling unveils distinct sex-related metabolic patterns in Nafld. Front Endocrinol. Lausanne. 14, 1230457 (2023).","journal-title":"Front Endocrinol. Lausanne."},{"key":"36704_CR25","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.jhep.2024.09.033","volume":"82","author":"S Ran","year":"2025","unstructured":"Ran, S. et al. Association of metabolic signatures of air pollution with MASLD: Observational and Mendelian randomization study. J. Hepatol. 82, 560\u2013570 (2025).","journal-title":"J. Hepatol."},{"key":"36704_CR26","doi-asserted-by":"publisher","first-page":"156051","DOI":"10.1016\/j.metabol.2024.156051","volume":"162","author":"A Vouilloz","year":"2025","unstructured":"Vouilloz, A. et al. Impaired unsaturated fatty acid elongation alters mitochondrial function and accelerates metabolic dysfunction-associated steatohepatitis progression. Metabolism 162, 156051 (2025).","journal-title":"Metabolism"},{"key":"36704_CR27","doi-asserted-by":"publisher","first-page":"10527","DOI":"10.1039\/D4FO01182A","volume":"15","author":"P Zhuang","year":"2024","unstructured":"Zhuang, P. et al. Circulating fatty acids and risk of severe non-alcoholic fatty liver disease in the UK biobank: A prospective cohort of 116 223 individuals. Food Funct. 15, 10527\u201310538 (2024).","journal-title":"Food Funct."},{"issue":"1","key":"36704_CR28","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1210\/clinem\/dgaf346","volume":"111","author":"S Palomurto","year":"2025","unstructured":"Palomurto, S. et al. Metabolic dysfunction-associated steatotic liver disease alters fatty acid profiles in the liver and adipose tissue. J. Clin. Endocrinol. Metab. 111(1), e23-31 (2025).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"36704_CR29","doi-asserted-by":"publisher","first-page":"e138889","DOI":"10.1371\/journal.pone.0138889","volume":"10","author":"S Cheng","year":"2015","unstructured":"Cheng, S. et al. Adipose tissue dysfunction and altered systemic amino acid metabolism are associated with non-alcoholic fatty liver disease. PLoS ONE 10, e138889 (2015).","journal-title":"PLoS ONE"},{"key":"36704_CR30","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.ajcnut.2024.09.017","volume":"120","author":"J Ha","year":"2024","unstructured":"Ha, J. et al. Dietary and lifestyle insulinemic potentials, plasma metabolome, and risk of diverticulitis: A prospective cohort study. Am. J. Clin. Nutr. 120, 1053\u20131062 (2024).","journal-title":"Am. J. Clin. Nutr."},{"key":"36704_CR31","first-page":"e16220","volume":"45","author":"I Alabdul Razzak","year":"2025","unstructured":"Alabdul Razzak, I., Fares, A., Stine, J. G. & Trivedi, H. D. The role of exercise in steatotic liver diseases: An updated perspective. Liver Int. Off. J. Int. Assoc. Stud. Liver. 45, e16220 (2025).","journal-title":"Liver Int. Off. J. Int. Assoc. Stud. Liver."},{"key":"36704_CR32","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrendo.2012.49","volume":"8","author":"BK Pedersen","year":"2012","unstructured":"Pedersen, B. K. & Febbraio, M. A. Muscles, exercise and obesity: Skeletal muscle as a secretory organ. Nat. Rev. Endocrinol. 8, 457\u2013465 (2012).","journal-title":"Nat. Rev. Endocrinol."},{"key":"36704_CR33","doi-asserted-by":"publisher","first-page":"6485","DOI":"10.1038\/s41598-022-10481-9","volume":"12","author":"AF Babu","year":"2022","unstructured":"Babu, A. F. et al. Effects of exercise on nafld using non-targeted metabolomics in adipose tissue, plasma, urine, and stool. Sci. Rep.-UK. 12, 6485 (2022).","journal-title":"Sci. Rep.-UK."},{"key":"36704_CR34","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12944-025-02565-y","volume":"24","author":"D Deng","year":"2025","unstructured":"Deng, D. et al. HIIT versus MICT in MASLD: Mechanisms mediated by gut-liver axis crosstalk, mitochondrial dynamics remodeling, and adipokine signaling attenuation. Lipids Health Dis. 24, 144 (2025).","journal-title":"Lipids Health Dis."},{"key":"36704_CR35","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","volume":"73","author":"G Targher","year":"2024","unstructured":"Targher, G., Byrne, C. D. & Tilg, H. MASLD: A systemic metabolic disorder with cardiovascular and malignant complications. Gut 73, 691\u2013702 (2024).","journal-title":"Gut"},{"key":"36704_CR36","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/S0140-6736(10)61272-X","volume":"376","author":"VG Athyros","year":"2010","unstructured":"Athyros, V. G. et al. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek atorvastatin and coronary heart disease evaluation (Greace) study: A post-hoc analysis. Lancet (London, Engl). 376, 1916\u20131922 (2010).","journal-title":"Lancet (London, Engl)."},{"key":"36704_CR37","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.jhep.2019.08.018","volume":"71","author":"AM Allen","year":"2019","unstructured":"Allen, A. M., Hicks, S. B., Mara, K. C., Larson, J. J. & Therneau, T. M. The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity\u2014a longitudinal cohort study. J. Hepatol. 71, 1229\u20131236 (2019).","journal-title":"J. Hepatol."},{"key":"36704_CR38","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1053\/j.gastro.2025.02.044","volume":"169","author":"ZM Younossi","year":"2025","unstructured":"Younossi, Z. M. et al. Global consensus recommendations for metabolic dysfunction-associated steatotic liver disease and steatohepatitis. Gastroenterology. 169, 1017-1032.e2 (2025).","journal-title":"Gastroenterology."},{"key":"36704_CR39","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.3748\/wjg.v30.i22.2829","volume":"30","author":"H Lv","year":"2024","unstructured":"Lv, H. & Liu, Y. Management of non-alcoholic fatty liver disease: Lifestyle changes. World J. Gastroenterol. 30, 2829\u20132833 (2024).","journal-title":"World J. Gastroenterol."},{"key":"36704_CR40","doi-asserted-by":"publisher","first-page":"6430","DOI":"10.1097\/JS9.0000000000002654","volume":"111","author":"J Sun","year":"2025","unstructured":"Sun, J. et al. Research letter: The global clinical trial landscape for non-alcoholic fatty liver disease (NAFLD) current status and future prospects. Int. J. Surg. 111, 6430\u20136434 (2025).","journal-title":"Int. J. Surg."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36704-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36704-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36704-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T23:04:40Z","timestamp":1771542280000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36704-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["36704"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-36704-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"4 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All participants provided written informed consent, and the study received ethical approval from the North West Multi-Centre Research Ethics Committee (REC ID: 16\/NW\/0274).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"7017"}}